8-K
filed March 4, 2022, 6:59 PM ET
ticker AMPX
CIK 0001899287
other material
confidence high
sentiment neutral
materiality 0.70
Kensington Capital IV closes $230M SPAC IPO; 23M units at $10, over-allotment exercised in full
Amprius Technologies, Inc.
- IPO of 23M units at $10/unit generated $230M gross proceeds; underwriter over-allotment option exercised for 3M units.
- Sponsor purchased 16M private placement warrants at $0.50/warrant, yielding $8M; warrants exercisable at $11.50/share.
- Net IPO proceeds of $230M placed in trust account with Continental Stock Transfer; funds held until business combination or 24-month deadline.
- Six new directors appointed to board (LaSorda, Nason, Pettersson, Quain, Runkle, Simoncini); audit, compensation, and governance committees formed.
- Company filed amended and restated memorandum and articles of association post-IPO.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Nicole Nason was appointed as Director at Amprius Technologies, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
On March 1, 2022, in connection with the IPO, Thomas LaSorda, Nicole Nason, Anders Pettersson, Mitchell Quain, Donald L. Runkle and Matthew Simoncini (the “New Directors” and, collectively with Justin Mirro, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Thomas LaSorda was appointed as Director at Amprius Technologies, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
On March 1, 2022, in connection with the IPO, Thomas LaSorda, Nicole Nason, Anders Pettersson, Mitchell Quain, Donald L. Runkle and Matthew Simoncini (the “New Directors” and, collectively with Justin Mirro, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Mitchell Quain was appointed as Director at Amprius Technologies, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
On March 1, 2022, in connection with the IPO, Thomas LaSorda, Nicole Nason, Anders Pettersson, Mitchell Quain, Donald L. Runkle and Matthew Simoncini (the “New Directors” and, collectively with Justin Mirro, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Matthew Simoncini was appointed as Director at Amprius Technologies, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
On March 1, 2022, in connection with the IPO, Thomas LaSorda, Nicole Nason, Anders Pettersson, Mitchell Quain, Donald L. Runkle and Matthew Simoncini (the “New Directors” and, collectively with Justin Mirro, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Donald L. Runkle was appointed as Director at Amprius Technologies, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
On March 1, 2022, in connection with the IPO, Thomas LaSorda, Nicole Nason, Anders Pettersson, Mitchell Quain, Donald L. Runkle and Matthew Simoncini (the “New Directors” and, collectively with Justin Mirro, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Anders Pettersson was appointed as Director at Amprius Technologies, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
On March 1, 2022, in connection with the IPO, Thomas LaSorda, Nicole Nason, Anders Pettersson, Mitchell Quain, Donald L. Runkle and Matthew Simoncini (the “New Directors” and, collectively with Justin Mirro, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.